首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1494343

北美流動止血劑市場預測至 2028 年 - 區域分析 - 按材料、產品、應用和最終用戶

North America Flowable Hemostats Market Forecast to 2028 - Regional Analysis - by Material, Product, Application, and End User

出版日期: 2024年03月14日 | 出版商:

The Insight Partners | 英文 122 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

北美可流動止血劑市場預計將從2022年的4.9474億美元成長到2028年的7.4249億美元。

導致產品創新的研發 (R&D) 活動推動北美可流動止血劑市場

醫療保健產業對止血劑產品的需求量很大。在過去的幾年中，許多止血劑產品已被開發並在多種外科手術中使用。研究人員正在進行深入的研究和開發活動，從而實現產品創新。例如，2019年12月，Ethicon（強生醫療器材公司）的新產品「SURGIFLO止血基質」。 SURGIFLOW 可流動止血產品可在手術時止血，並且比 FLOSEAL（Baxter 製造）更快。此外，2018 年 1 月，領先的止血設備開發商和行銷商 Z-Medica, LLC 推出了 QuikClot Control+，它可以幫助拯救生命並滿足全國各地醫院未滿足的需求。 QuikClot Control+ 適用於暫時控制出現 III 級或 IV 級出血的患者的內臟器官間隙出血。它甚至可以用於控制嚴重流血的傷口，例如手術傷口和外傷。因此，預計導致產品創新的研發活動將在預測期內推動整個可流動止血劑市場的成長。

北美可流動止血劑市場概況

北美流動止血劑市場收入及 2028 年預測（百萬美元）

北美流動止血劑市場細分

北美流動止血劑市場分為材料、產品、應用、最終用戶和國家。

根據材料，北美流動止血劑市場分為牛明膠和豬明膠。 2022 年，牛明膠細分市場在北美流動止血劑市場中佔據更大佔有率。

就產品而言，北美可流動止血器市場分為組合止血器、被動止血器和主動式止血器。 2022 年，組合止血劑細分市場在北美可流動止血劑市場中佔據最大佔有率。

根據應用，北美可流動止血劑市場分為一般外科、心臟外科、血管外科、骨科外科、神經和脊椎外科等。 2022 年，一般外科細分市場在北美流動止血劑市場中佔最大佔有率。

根據最終用戶，北美可流動止血劑市場分為醫院和診所、門診手術中心等。 2022 年，醫院和診所在北美流動止血劑市場中佔據最大佔有率。

依國家分類，北美流動止血劑市場分為美國、加拿大和墨西哥。 2022 年，美國將主導北美流動止血劑市場。

Baxter International Inc、Ethicon (Johnson & Johnson)、Pfizer Inc、Teleflex Incorporated、3-D Matrix Medical Technology、Biom'up 和 Aegis Lifesciences 是北美流動止血劑市場上的一些領先公司。

概述
2021 年及 2028 年北美可流動止血劑市佔率（按產品）
組合止血鉗
- 概述
- 組合止血器：北美可流動止血器市場 - 收入和 2028 年預測
被動止血器
- 概述
- 被動止血器：北美可流動止血器市場 - 收入和 2028 年預測
主動止血器
- 概述
- 主動止血器：北美可流動止血器市場 - 收入和 2028 年預測

第 9 章：北美可流動止血劑市場 - 按應用

概述
2021 年及 2028 年北美可流動止血劑市佔率（按應用分類）（%）
一般外科
- 概述
- 一般外科：北美可流動止血劑市場 - 收入和 2028 年預測
心臟外科
- 概述
- 心臟手術：北美可流動止血劑市場 - 收入和 2028 年預測
血管外科
- 概述
- 血管外科：北美可流動止血劑市場 - 收入和 2028 年預測
骨科手術
- 概述
- 骨科手術：北美可流動止血劑市場 - 收入和 2028 年預測
神經和脊椎外科
- 概述
- 神經和脊椎外科：北美可流動止血劑市場 - 收入和 2028 年預測
其他
- 概述
- 其他：北美可流動止血劑市場 - 收入和 2028 年預測

第 10 章：北美可流動止血器市場分析 - 按最終用戶

概述
2021 年和 2028 年北美可流動止血劑市場佔有率（按最終用戶分類）（%）
醫院和診所
門診手術中心
其他

第 11 章：北美可流動止血劑市場收入和 2028 年預測 - 國家分析

北美洲
- 美國
- 加拿大
- 墨西哥

第 12 章：北美可流動止血劑市場-產業格局

概述
可流動止血劑市場的成長策略（%）
有機發展
- 概述
無機發展
- 概述

第 13 章：公司簡介

Baxter International Inc
Ethicon (Johnson & Johnson)
Pfizer Inc.
Teleflex Incorporated
3-D Matrix Medical Technology
Biom'up
Aegis Lifesciences

第 14 章：附錄

簡介目錄圖表

Product Code: BMIRE00029826

The North America flowable hemostats market is expected to grow from US$ 494.74 million in 2022 to US$ 742.49 million by 2028. It is estimated to grow at a CAGR of 7.0% from 2022 to 2028.

Research and Development (R&D) Activities Leading to Product Innovations Fuel North America Flowable Hemostats Market

Hemostat products are high in demand in the healthcare industry. Over the past several years, many hemostat products have been developed and utilized in several surgical procedures. Researchers are carrying out intensive research and development activities resulting in product innovations. For Instance, In December 2019, Ethicon's (Johnson & Johnson Medical Device Companies) new product, "SURGIFLO Hemostatic Matrix." SURGIFLOW flowable hemostatic product stops bleeding while performing surgery and is faster than FLOSEAL (manufactured by Baxter). Furthermore, In January 2018, Z-Medica, LLC, a leading developer and marketer of hemostatic devices introduced QuikClot Control+ which can help save lives and fill the unmet need of hospitals across the country. QuikClot Control+ is indicated for temporary control of internal organ space bleeding for patients displaying class III or class IV bleeding. It may even be used to control severe bleeding wounds such as surgical wounds and traumatic injuries. Thus, research and development activities leading to product innovations are predicted to deliver an impetus for the growth of the overall flowable hemostats market during the forecast period.

North America Flowable Hemostats Market Overview

North America Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Million)

North America Flowable Hemostats Market Segmentation

The North America flowable hemostats market is segmented into material, product, application, end user, and country.

Based on material, the North America flowable hemostats market is bifurcated into bovine gelatin & porcine gelatin. The bovine gelatin segment held a larger share of the North America flowable hemostats market in 2022.

In terms of product, the North America flowable hemostats market is segmented into combination hemostats, passive hemostats, and active hemostats. The combination hemostats segment held the largest share of the North America flowable hemostats market in 2022.

Based on Application, the North America flowable hemostats market is categorized into general surgery, cardiac surgery, vascular surgery, orthopedic surgery, neuro and spine surgery, and others. The general surgery segment held the largest share of the North America flowable hemostats market in 2022.

Based on end user, the North America flowable hemostats market is segmented into hospitals and clinics, ambulatory surgery centers, and others. The hospitals and clinics segment held the largest share of the North America flowable hemostats market in 2022.

By country, the North America flowable hemostats market is categorized into the US, Canada, and Mexico. The US dominated the North America flowable hemostats market in 2022.

Baxter International Inc, Ethicon (Johnson & Johnson), Pfizer Inc, Teleflex Incorporated, 3-D Matrix Medical Technology, Biom'up, and Aegis Lifesciences are some of the leading companies operating in the North America North America flowable hemostats market.

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 North America Flowable Hemostats Market - By Material
- 1.3.2 North America Flowable Hemostats Market - By Product
- 1.3.3 North America Flowable Hemostats Market - By Application
- 1.3.4 North America Flowable Hemostats Market - By End User
- 1.3.5 North America Flowable Hemostats Market - By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Flowable Hemostats Market - Market Landscape

4.1 Overview
4.2 North America PEST Analysis
- 4.2.1 North America PEST Analysis
4.3 North America Experts Opinion

5. North America Flowable Hemostats Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increasing Number of Injuries and Surgical Procedures
- 5.1.2 Rising Geriatric Population
5.2 Market Restraints
- 5.2.1 Shortage of Skilled Professionals and Poor Reimbursement Policies
5.3 Market Opportunities
- 5.3.1 Increasing Number of Hospitals and Surgical Centers
5.4 Future Trends
- 5.4.1 Research and Development (R&D) Activities Leading to Product Innovations
5.5 Impact Analysis

6. Flowable Hemostats Market - North America Analysis

6.1 North America Flowable Hemostats Market Revenue Forecast & Analysis

7. North America Flowable Hemostats Market Revenue Forecast & Analysis

7.1 North America Flowable Hemostats Market Analysis - By Material
7.2 North America Flowable Hemostats Market Share, by Material, 2021 and 2028 (%)
7.3 Bovine Gelatin
- 7.3.1 Overview
- 7.3.2 Bovine Gelatin: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
7.4 Porcine Gelatin
- 7.4.1 Overview
- 7.4.2 Porcine Gelatin: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)

8. North America Flowable Hemostats Market- By Product

8.1 Overview
8.2 North America Flowable Hemostats Market Share, by Product, 2021 and 2028 (%)
8.3 Combination Hemostat
- 8.3.1 Overview
- 8.3.2 Combination Hemostat: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
8.4 Passive Hemostat
- 8.4.1 Overview
- 8.4.2 Passive Hemostat: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
8.5 Active Hemostat
- 8.5.1 Overview
- 8.5.2 Active Hemostat: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)

9. North America Flowable Hemostats Market- By Application

9.1 Overview
9.2 North America Flowable Hemostats Market Share, by Application, 2021 and 2028 (%)
9.3 General Surgery
- 9.3.1 Overview
- 9.3.2 General Surgery: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
9.4 Cardiac Surgery
- 9.4.1 Overview
- 9.4.2 Cardiac Surgery: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
9.5 Vascular Surgery
- 9.5.1 Overview
- 9.5.2 Vascular Surgery: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
9.6 Orthopedic Surgery
- 9.6.1 Overview
- 9.6.2 Orthopedic Surgery: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
9.7 Neuro and Spine Surgery
- 9.7.1 Overview
- 9.7.2 Neuro and Spine Surgery: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
9.8 Others
- 9.8.1 Overview
- 9.8.2 Others: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)

10. North America Flowable Hemostats Market Analysis - By End User

10.1 Overview
10.2 North America Flowable Hemostats Market Share, by End User, 2021 and 2028, (%)
10.3 Hospitals and Clinics
- 10.3.1 Overview
- 10.3.2 Hospitals and Clinics: North America Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)
10.4 Ambulatory Surgery Centers
- 10.4.1 Overview
- 10.4.2 Ambulatory Surgery Centers: North America Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)
10.5 Others
- 10.5.1 Overview
- 10.5.2 Others: North America Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)

11. North America Flowable Hemostats Market Revenue and Forecasts to 2028 - Country Analysis

11.1 North America: Flowable Hemostats Market
- 11.1.1 Overview
- 11.1.2 North America: Flowable Hemostats Market, by Country, 2022 & 2028 (%)
  - 11.1.2.1 US: Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.2.1.1 Overview
  - 11.1.2.2 US: Flowable Hemostats Market - Revenue and Forecast to 2028 (USD Million)
    - 11.1.2.2.1 US: Flowable Hemostats Market, by Material- Revenue and Forecast to 2028 (USD Million)
    - 11.1.2.2.2 US: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
    - 11.1.2.2.3 US: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
    - 11.1.2.2.4 US: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
  - 11.1.2.3 Canada: Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.2.3.1 Overview
    - 11.1.2.3.2 Canada: Flowable Hemostats Market - Revenue and Forecast to 2028 (USD Million)
    - 11.1.2.3.3 Canada: Flowable Hemostats Market, by Material- Revenue and Forecast to 2028 (USD Million)
    - 11.1.2.3.4 Canada: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
    - 11.1.2.3.5 Canada: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
    - 11.1.2.3.6 Canada: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
  - 11.1.2.4 Mexico: Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.2.4.1 Overview
    - 11.1.2.4.2 Mexico: Flowable Hemostats Market - Revenue and Forecast to 2028 (USD Million)
    - 11.1.2.4.3 Mexico: Flowable Hemostats Market, by Material- Revenue and Forecast to 2028 (USD Million)
    - 11.1.2.4.4 Mexico: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
    - 11.1.2.4.5 Mexico: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
    - 11.1.2.4.6 Mexico: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)

12. North America Flowable Hemostats Market-Industry Landscape

12.1 Overview
12.2 Growth Strategies in the Flowable Hemostats Market (%)
12.3 Organic Developments
- 12.3.1 Overview
12.4 Inorganic Developments
- 12.4.1 Overview

13. Company Profiles

13.1 Baxter International Inc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Ethicon (Johnson & Johnson)
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Pfizer Inc.
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Teleflex Incorporated
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 3-D Matrix Medical Technology
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Biom'up
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Aegis Lifesciences
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments

14. Appendix

14.1 About The Insight Partners
14.2 North America Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. US: Flowable Hemostats Market, by Material - Revenue and Forecast to 2028 (USD Million)
Table 2. US: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
Table 3. US: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
Table 4. US: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
Table 5. Canada: Flowable Hemostats Market, by Material - Revenue and Forecast to 2028 (USD Million)
Table 6. Canada: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
Table 7. Canada: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
Table 8. Canada: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
Table 9. Mexico: Flowable Hemostats Market, by Material - Revenue and Forecast to 2028 (USD Million)
Table 10. Mexico: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
Table 11. Mexico: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
Table 12. Mexico: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
Table 13. Organic Developments in the Flowable Hemostats Market
Table 14. Inorganic Developments in the Flowable Hemostats Market
Table 15. North America Glossary of Terms

List Of Figures

Figure 1. North America Flowable Hemostats Market Segmentation
Figure 2. North America Flowable Hemostats Market, By Country
Figure 3. North America Flowable Hemostats Market Overview
Figure 4. Bovine Gelatin Holds Maximum Share in North America Flowable Hemostats Market
Figure 5. North America Flowable Hemostats Market, by Country (US$ Million)
Figure 6. North America Flowable Hemostats Market, Market Attractiveness
Figure 7. North America: PEST Analysis
Figure 8. North America Experts Opinion
Figure 9. Impact Analysis
Figure 10. North America Flowable Hemostats Market - Revenue Forecast and Analysis - 2020- 2028
Figure 11. North America Flowable Hemostats market Share, by Material, 2021 and 2028 (%)
Figure 12. Bovine Gelatin: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
Figure 13. Porcine Gelatin: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
Figure 14. North America Flowable Hemostats Market Share, by Product, 2021 and 2028 (%)
Figure 15. Combination Hemostat: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
Figure 16. Passive Hemostat: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
Figure 17. Active Hemostat: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
Figure 18. North America Flowable Hemostats Market Share, by Application, 2021 and 2028 (%)
Figure 19. General Surgery: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
Figure 20. Cardiac Surgery: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
Figure 21. Vascular Surgery: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
Figure 22. Orthopedic Surgery: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
Figure 23. Neuro and Spine Surgery: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
Figure 24. Others: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
Figure 25. North America Flowable Hemostats Gown Market Share, by End User, 2021 and 2028 (%)
Figure 26. Hospitals and Clinics: North America Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)
Figure 27. Ambulatory Surgery Centers: North America Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)
Figure 28. Others: North America Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)
Figure 29. North America Flowable Hemostats Market Revenue Overview, by Country, 2021 (US$ MN)
Figure 30. North America: Flowable Hemostats Market, by Country, 2022 & 2028 (%)
Figure 31. US: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)
Figure 32. Canada: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)
Figure 33. Mexico: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)
Figure 34. Growth Strategies in the Flowable Hemostats Market (%)